Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics.
Cacabelos R, Carrera I, Martínez O, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Nebril L, Tellado I, Cacabelos N, Pego R, Naidoo V, Carril JC.
Cacabelos R, et al. Among authors: naidoo v.
Med Res Rev. 2021 Sep;41(5):2841-2886. doi: 10.1002/med.21838. Epub 2021 Jun 9.
Med Res Rev. 2021.
PMID: 34106485